Pathwork Diagnostics' Series C - II Round

Pathwork Diagnostics raised a round of funding on December 01, 2012. Investors include Sand Hill Angels.

Pathwork Diagnostics Inc. is a privately held company that develops and delivers innovative molecular diagnostics for oncology. Pathwork's Tissue of Origin Test identifies the source of cancers that a…

Articles about Pathwork Diagnostics' Series C - II Round: